| ID | Type | Location (GRCh37) | Location (GRCh38) | Length | GC content |
|---|---|---|---|---|---|
| hsa_CCDC66_0001400 | Intron-Intron | chr3:56594528-56594683 | chr3:56560500-56560655 | 156 nt | 0.5000 |
| hsa_CCDC66_0001700 | Intron-Exon-Intron | chr3:56594890-56600787 | chr3:56560862-56566759 | 317 nt | 0.3533 |
| hsa_CCDC66_0001800 | Intron-Exon-Intron | chr3:56594890-56601081 | chr3:56560862-56567053 | 255 nt | 0.4078 |
| hsa_CCDC66_0001900 | Intron-Exon-Intron | chr3:56594890-56605330 | chr3:56560862-56571302 | 273 nt | 0.3480 |
| hsa_CCDC66_0002000 | Intron-Exon-Intron | chr3:56594890-56627769 | chr3:56560862-56593741 | 122 nt | 0.4426 |
| hsa_CCDC66_0001600 | Intron-Exon-Intron | chr3:56594890-56651633 | chr3:56560862-56617605 | 250 nt | 0.3320 |
| hsa_CCDC66_0002100 | Intron-Exon-Intron | chr3:56594986-56605330 | chr3:56560958-56571302 | 250 nt | 0.2440 |
| hsa_CCDC66_0002200 | Intron-Exon-Intron | chr3:56594986-56628056 | chr3:56560958-56594028 | 140 nt | 0.4214 |
| hsa_CCDC66_0002300 | Intron-Exon-Intron | chr3:56594986-56653929 | chr3:56560958-56619901 | 180 nt | 0.4056 |
| hsa_CCDC66_0002400 | Intron-Exon-Intron | chr3:56595285-56605330 | chr3:56561257-56571302 | 250 nt | 0.2520 |
A study in human lung adenocarcinoma cells demonstrated that the circCCDC66 increases epithelial-mesenchymal transition and drug resistance [Huang et al. DOI:10.3390/cells11091381].